63 million Americans are now caring for loved ones with chronic, disabling, or serious health conditions, according to a new report from AARP and the National Alliance for Caregiving.

A new study finds exposure to PFAS may disrupt the body’s metabolism — increasing the risk for type 2 diabetes.

In a new study, participants administered low doses of CBD for 28 days experienced liver enzyme elevations greater than 3 times the upper limit of normal.

People who quit taking anti-obesity meds, including popular GLP-1 receptor agonists, may regain a significant amount of weight after eight weeks, a new study finds.

A new study finds kids given smartphones before the age of 13 are more likely to have poorer mental health by the age of 18.

A new study finds patients with type 2 diabetes who take GLP-1 receptor agonists are 27% more likely to develop gastroesophageal reflux disease (GERD) compared to those taking other common drugs called SGLT-2 inhibitors.

A new study finds both added sugars and artificial sweeteners are associated with a higher risk of early puberty, especially in children with a genetic predisposition.

Young women who suffer from PMS or PMDD are 10% more likely to develop heart disease later in life, a new study finds.

Calls to U.S. poison control centers involving nicotine pouches and young kids soared 763% from 2020 to 2023.